XML 42 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Weighted Average Assumptions for Options Granted
The Company used the following weighted average assumptions for options granted during the nine months ended September 30, 2023:
Weighted Average: Nine Months Ended September 30, 2023
Expected term6.2 years
Expected volatility75.4 %
Risk-free rate3.6 %
Expected dividends— %
Schedule of Service Based Stock Options Activity
The following table summarizes activity of service period-based stock options during the nine months ended September 30, 2023:
Weighted Average
(In thousands except per share data and remaining contractual term)Number of
Options
Exercise
Price
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding at December 31, 20229,397 $4.21 6.2$44 
Options Granted2,650 1.79 
Options Exercised— — — 
Options Forfeited(1,171)3.98 
Outstanding at September 30, 202310,876 $3.64 6.1$*
Exercisable at September 30, 20237,507 $4.32 4.6$*
*The aggregate intrinsic values in the table above are based on the Company’s stock price of $1.46, which is the closing price of the Company’s stock on the last day of business for the period ended September 30, 2023.
Summary of Activity of Restricted Stock Units and Restricted Stock Awards
The following table summarizes activity of RSUs during the nine months ended September 30, 2023:
(In thousands except per share fair value)Number of RSUsWeighted Average
Fair Value
Unvested shares at December 31, 2022650 $2.77 
Granted429 1.81 
Vested(327)2.83 
Forfeited(75)2.35 
Unvested shares at September 30, 2023677 $2.18 
Expected to vest at September 30, 2023677 $2.18 
The following table summarizes activity of restricted stock awards during the periods indicated:
(In thousands except per share fair value)Number of AwardsWeighted Average Fair Value
Unvested shares at December 31, 2022183 $3.25 
Granted— — 
Vested(16)$4.23 
Forfeited— — 
Unvested shares at September 30, 2023167 $3.15 
Expected to vest as of September 30, 2023167 $3.15 
Schedule of Share-Based Compensation
Total share-based compensation expense was as follows:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands)2023202220232022
Share-based compensation expense
Cost of sales$87 $73 $253 $203 
Sales and marketing180 414 879 1,134 
Research and development247 252 746 730 
General and administrative603 490 1,836 2,346 
Total$1,117 $1,229 $3,714 $4,413